Linde (LIN) stock rises as company sets Feb. 5 earnings date — what investors watch next
10 January 2026
1 min read

Linde (LIN) stock rises as company sets Feb. 5 earnings date — what investors watch next

New York, Jan 10, 2026, 16:55 (EST) — The market has closed.

  • Linde scheduled its fourth-quarter 2025 results for Feb. 5, with a webcast starting at 9 a.m. EST
  • Shares ended Friday roughly 1% higher, closing at $444.08
  • U.S. inflation figures set for Jan. 13 may shake up expectations for rate cuts just before earnings season kicks off

Linde plc shares ended the last session 1% higher at $444.08, marking a key moment as the industrial gases company approaches earnings season.

U.S. stocks have hit record highs, and with every new data point nudging rate expectations, even minor shifts can impact steady earners like Linde. Now, the stock’s next major catalyst is set on the calendar.

Linde’s main concern is straightforward: demand and pricing. Investors are watching to see if volume trends hold steady, particularly in Europe, and what the company projects for 2026 margins amid ongoing industry cost pressures.

Linde plans to publish its fourth-quarter 2025 financial results by 6 a.m. EST on Feb. 5, followed by a conference call at 9 a.m. EST. The company, which posted $33 billion in sales for 2024, provides gases and engineering services across sectors like chemicals, energy, healthcare, and electronics. 1

On Friday, the stock fluctuated between $437.17 and $445.05, holding steady in the upper half of its 52-week range of $387.78 to $486.38, according to MarketWatch data. 2

Linde followed a market that steadily pushed higher. The S&P 500 closed at a record on Friday, shrugging off a softer U.S. jobs report that failed to dent bets on Federal Reserve rate cuts later this year. “Payrolls were a little bit light relative to consensus, but still fairly strong numbers,” noted Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder. 3

Shares in industrial gas rivals climbed, with Air Products gaining roughly 1%, matching Linde’s advance, according to MarketWatch’s market data. 4

The upcoming earnings report follows Linde’s cautious outlook on Europe from late last year. In October, the company beat third-quarter earnings estimates but warned of softer volumes in its Europe, Middle East, and Africa segment, which accounts for roughly a quarter of its sales. It also projected fourth-quarter adjusted earnings per share—excluding certain one-offs—between $4.10 and $4.20. 5

Before Linde’s earnings hit, macro data might take the spotlight. The Labor Department will release December 2025’s consumer price index on Tuesday, Jan. 13, at 8:30 a.m. ET. Producer price figures come out the very next day, per the agency’s schedule. 6

The Fed’s upcoming policy meeting is set for Jan. 27-28, a key date for rate-cut speculation that often moves valuation-sensitive large caps. 7

That said, the setup works against Linde as well. Should February’s update reveal European volumes continuing to drop or prices easing, a stock trading just under 10% from its 52-week peak could quickly lose investor confidence.

Investors are eyeing Linde’s earnings report set for Feb. 5, due out before the U.S. market opens, with management’s conference call to follow at 9 a.m. 8

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Shell stock in focus for Monday as Venezuela sanctions could ease “next week” and buybacks roll on
Previous Story

Shell stock in focus for Monday as Venezuela sanctions could ease “next week” and buybacks roll on

Intel stock jumps 11% on Trump praise — what INTC investors watch next
Next Story

Intel stock jumps 11% on Trump praise — what INTC investors watch next

Go toTop